The stock is in a pronounced downtrend from its recent highs, trading at $144.07, which is approximately 69% of its 52-week range ($105.32 to $207.52), indicating it is much closer to its yearly low than its high and suggesting a significant loss of momentum from previous peaks. The 1-year price change of +23.98% is positive but masks severe recent weakness, as evidenced by the 6-month decline of -28.13% and a year-to-date drop of -14.17%, signaling a substantial reversal from earlier strength. Recent momentum is decidedly negative and diverging sharply from the longer-term uptrend, with the stock down -1.65% over the past month and -1.72% over the past three months, while the S&P 500 (SPY) gained +9.98% and +4.14% over the same periods, resulting in severe negative relative strength readings of -11.63 and -5.86, respectively, which highlights significant underperformance and selling pressure.

Key technical support is firmly established at the 52-week low of $105.32, while immediate overhead resistance sits near the 52-week high of $207.52; a decisive breakdown below the $105 support would signal a complete failure of the long-term bull thesis and likely trigger further capitulation. The stock exhibits high volatility with a beta of 1.674, meaning it is approximately 67% more volatile than the broader market, which amplifies both upside and downside moves and necessitates larger risk buffers for position sizing. The price action shows the stock recently bounced from a low near $128 in mid-April to the current $144 level, but this remains a weak rally within a broader corrective pattern, and sustained trade above the $150-$160 zone is needed to suggest a more durable low is in place.

Revenue growth remains robust but has shown sequential deceleration; Q4 2025 revenue reached $1.407 billion, representing a strong 70% year-over-year growth, however, this marks a slowdown from the 93% YoY growth seen in Q3 2025 ($1.181 billion) and the 104% YoY growth in Q2 2025 ($1.004 billion). Segment data from the latest quarter shows a balanced contribution, with Commercial revenue at $677.1 million and Government revenue at $729.7 million, indicating both pillars are driving top-line expansion, though the commercial segment's growth is particularly critical for the long-term diversification narrative. The decelerating growth trajectory, while still exceptional, introduces execution risk into an investment case predicated on hyper-growth.

Profitability has transformed dramatically, with the company now generating substantial net income; Q4 2025 net income was $608.7 million, yielding a net margin of 43.3%, and gross margin remained stellar at 84.65%. Margins have expanded sequentially and year-over-year, as evidenced by the operating margin rising from 0.3% in Q4 2024 to 40.9% in Q4 2025, demonstrating powerful operating leverage as revenue scales. The transition from minimal profitability to industry-leading margins (gross margin of 82.37% and operating margin of 31.59% on a trailing basis) underpins the bull case, but such elevated levels invite scrutiny on sustainability, especially if competitive pressures or sales mix shift.

The balance sheet is exceptionally strong with minimal debt, evidenced by a debt-to-equity ratio of only 0.031, and superb liquidity with a current ratio of 7.11. The company is a prolific cash generator, with trailing twelve-month free cash flow of $2.102 billion and an ROE of 22.0%, indicating efficient use of shareholder equity. This robust financial health, characterized by a fortress balance sheet and strong internal cash generation, provides significant flexibility to fund growth initiatives, weather downturns, and potentially return capital, substantially mitigating financial risk for investors.